Autnami

Autnami combines Metformin Hydrochloride and Linagliptin for oral use, aiding blood sugar management. This dual-action medication supports metabolic health and is manufactured by Sandoz Pharmaceuticals D.D.

Autnami is primarily used to manage blood sugar levels in adults with type 2 diabetes. It combines Metformin Hydrochloride, which helps reduce glucose production in the liver, and Linagliptin, which works to increase insulin production. Together, these active ingredients help control blood sugar levels, making it a common choice for those seeking to manage their diabetes effectively.

Common effects of Autnami may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or a mild metallic taste. These effects are generally temporary and often subside as the body adjusts to the medication.

Autnami should be used with caution in individuals with kidney or liver issues. It is important to consult a healthcare provider before starting this medication, especially if you have a history of pancreatic or heart problems. Always follow the prescribed dosage and monitor blood sugar levels regularly.

Autnami may interact with certain medications, including other diabetes treatments, blood pressure medications, and diuretics. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be limited as it can affect blood sugar levels and increase the risk of side effects.